triazolam has been researched along with Jet Lag in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Jet lag is often cited as a cause of poor sporting performance." | 1.34 | Beating jet lag. ( Fuard, MH; Milne, CJ, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Milne, CJ | 1 |
| Fuard, MH | 1 |
2 other studies available for triazolam and Jet Lag
| Article | Year |
|---|---|
[Strategies against jet lag].
Topics: Anti-Anxiety Agents; Caffeine; Central Nervous System Stimulants; Complementary Therapies; Homeopath | 2004 |
Beating jet lag.
Topics: Football; GABA Modulators; Humans; Jet Lag Syndrome; Male; Melatonin; Task Performance and Analysis; | 2007 |